Sorrento Therapeutics Inc (SRNE): It is very important that Sorrento has e...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: 1776club post# 11048

Wednesday, 08/11/2021 8:10:16 PM

Wednesday, August 11, 2021 8:10:16 PM

It is very important that Sorrento has exclusive rights to the C1 technology for vaccine development for 60% of the world population. North and South America, Europe, large parts of Asia including China and Japan.
Sorrento already has 500,000 sq.ft. of manufacturing capacity divided between the US and China.
These facilities, along with the C1 technology will allow for rapid, large scale manufacture of affordable vaccines that will control all potential Covid variants. Sorrento now will have both the second generation mRNA and C1 technologies to lead the world in dealing with current and future pandemics ! The following presentation from ZAPI is very enlightening...
https://irdirect.net/prviewer/release_only/id/4651797

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM